Review article: the endocannabinoid system in liver disease, a potential therapeutic target.

Basu, P P; Aloysius, M M; Shah, N J; Brown, R S

Basu, P P; Aloysius, M M; Shah, N J; Brown, R S.

Affiliation

Basu PP; Division of Digestive and Liver Diseases and Center for Liver Disease and Transplantation, Columbia University Medical Center, NY, USA; King's County Hospital Medical Center, Brooklyn, NY, USA.

Aliment Pharmacol Ther ; 39(8): 790-801, 2014 Apr.

Article in En | MEDLINE | ID: mdl-24612021

Subject(s)

Cannabinoid Receptor Modulators/therapeutic use; Endocannabinoids/metabolism; Liver Diseases/drug therapy; Animals; Cannabinoid Receptor Modulators/adverse effects; Cannabinoid Receptor Modulators/pharmacology; Drug Design; Drug Evaluation, Preclinical; Humans; Liver Diseases/physiopathology; Molecular Targeted Therapy; Receptors, Cannabinoid/drug effects; Receptors, Cannabinoid/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endocannabinoids / Cannabinoid Receptor Modulators / Liver Diseases Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2014 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google